Biotechnology Company Receives Positive Listing Determination From Nasdaq

On July 31, 2024, Exicure, Inc. ("Exicure" or the "Company") (NASDAQ: XCUR) made a pivotal announcement regarding its listing status on the Nasdaq Capital Market. The Company received formal notice from the Nasdaq Hearings Panel ("Panel") that it has been granted continued listing on the exchange, provided it meets all necessary criteria by September 16, 2024. $Exicure (XCUR.US)$